FTC sues main pharmacy advantage administrators about insulin costs The agency brought action versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the listing price of daily life-saving insulin medication. Investment in digital health and fitness businesses achieved years-very low amounts final calendar https://ayahealthcareaddress38272.blogrelation.com/36738546/considerations-to-know-about-healthcare-news